Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 5/20 | 0.35 |
| ▸ | ADRB1 | P08588 | 5/20 | 0.35 |
| ▸ | ADRB3 | P13945 | 5/20 | 0.35 |
| ▸ | LNPEP | Q9UIQ6 | 7/20 | 0.33 |
| ▸ | COPS5 | Q92905 | 1/20 | 0.32 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9304994 | 1.00 | ADRB2 (0.35) | ADRB2ADRB1ADRB3LNPEPCOPS5 | |
| SCHEMBL9304656 | 0.78 | ADRB2 (0.54) | ADRB2ADRB1ADRB3 | |
| SCHEMBL9304652 | 0.78 | ADRB2 (0.54) | ADRB2ADRB1ADRB3 | |
| SCHEMBL9303990 | 0.75 | ADRB2 (0.55) | ADRB2ADRB1ADRB3 | |
| SCHEMBL9303995 | 0.75 | ADRB2 (0.55) | ADRB2ADRB1ADRB3 | |
| SCHEMBL14895223 | 0.70 | NOS1 (0.45) | SMYD3BLM | |
| SCHEMBL17933366 | 0.69 | FDPS (0.35) | SMYD3BLM | |
| SCHEMBL21533859 | 0.66 | — | — | |
| SCHEMBL21325317 | 0.66 | RAB9A (0.32) | L3MBTL1 | |
| SCHEMBL22751232 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5321036-A | Treatment of diabetes, obesity and gastrointestinal disorders | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-06-14 | — | — | US | disclosed |